GnRH agonists

Results: 40



#Item
31Vantas™ (histrelin implant) DESCRIPTION Vantas™ (histrelin implant) is a sterile non-biodegradable, diffusion-controlled reservoir drug delivery system designed to deliver histrelin continuously for 12 months upon su

Vantas™ (histrelin implant) DESCRIPTION Vantas™ (histrelin implant) is a sterile non-biodegradable, diffusion-controlled reservoir drug delivery system designed to deliver histrelin continuously for 12 months upon su

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-01-20 15:41:22
32HIGHLIGHTS OF PRESCRIBING INFORMATION •	  These highlights do not include all the information needed to use

HIGHLIGHTS OF PRESCRIBING INFORMATION • These highlights do not include all the information needed to use

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-01-20 14:36:46
33LUPRON DEPOT® 7.5 mg  (leuprolide acetate for depot suspension) Rx only DESCRIPTION

LUPRON DEPOT® 7.5 mg (leuprolide acetate for depot suspension) Rx only DESCRIPTION

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-07-11 13:47:34
34NDA[removed]S[removed]Lupron Depot 7.5 mg (leuprolide acetate for depot

NDA[removed]S[removed]Lupron Depot 7.5 mg (leuprolide acetate for depot

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-01-20 14:36:45
35SUPERLORIN P Insert 4.25X11 15jun12

SUPERLORIN P Insert 4.25X11 15jun12

Add to Reading List

Source URL: www.fda.gov

Language: English
36Date of Index Listing:  June 25, 2012 FREEDOM OF INFORMATION SUMMARY ORIGINAL REQUEST FOR ADDITION TO THE INDEX OF LEGALLY MARKETED UNAPPROVED NEW ANIMAL

Date of Index Listing: June 25, 2012 FREEDOM OF INFORMATION SUMMARY ORIGINAL REQUEST FOR ADDITION TO THE INDEX OF LEGALLY MARKETED UNAPPROVED NEW ANIMAL

Add to Reading List

Source URL: www.fda.gov

Language: English
37DEPARTMENT OF HEALTH & HUMAN SERVICES  Public Health Service Food and Drug Administration Silver Spring, MD 20993

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993

Add to Reading List

Source URL: www.fda.gov

Language: English
38C:�Documents-�-WL drafts 2004104_Viadur_WarningLetter Final�D;.doc

C:Documents--WL drafts 2004104_Viadur_WarningLetter FinalD;.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
39

PDF Document

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
40

PDF Document

Add to Reading List

Source URL: www.britishfibroidtrust.org.uk

Language: English - Date: 2009-09-27 18:49:41